Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?

被引：0
|
作者：
Childs, Daniel S. [1 ]
Orme, Jacob J. [1 ]
Ravi, Praful [2 ]
机构：
[1] Mayo Clin, Dept Oncol, 200 First St SW, Rochester, MN 55905 USA
[2] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 10期
关键词：
ABIRATERONE ACETATE; ENZALUTAMIDE; INTERMITTENT; SURVIVAL; RISK;
D O I：
10.1200/JCO.23.02410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Identification of clinically significant prostate cancer by prostate-specific antigen screening
    Smith, RP
    Malkowicz, SB
    Whittington, R
    VanArsdalen, K
    Tochner, Z
    Wein, A
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (11) : 1227 - 1230
  • [2] Prostate-specific antigen and prostate cancer
    Rosalki, SB
    Rutherford, FJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
  • [3] Prostate-specific Antigen Pox Virus Vaccination for Recurrent Prostate Cancer
    Wirth, Manfred P.
    Froehner, Michael
    EUROPEAN UROLOGY, 2015, 68 (03) : 372 - 373
  • [4] SERUM PROSTATE-SPECIFIC ANTIGEN AND THE BIOLOGIC PROGRESSION OF PROSTATE-CANCER
    KABALIN, JN
    MCNEAL, JE
    JOHNSTONE, IM
    STAMEY, TA
    UROLOGY, 1995, 46 (01) : 65 - 70
  • [5] BIOMARKERS FOR PROSTATE CANCER DETECTION AND, PROGRESSION: BEYOND PROSTATE-SPECIFIC ANTIGEN
    Berney, Daniel M.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (03) : 185 - 194
  • [6] Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
    Perner, Sven
    Hofer, Matthias D.
    Kim, Robert
    Shah, Rajal B.
    Li, Haojie
    Moeller, Peter
    Hautmann, Richard E.
    Gschwend, Juergen E.
    Kuefer, Rainer
    Rubin, Mark A.
    HUMAN PATHOLOGY, 2007, 38 (05) : 696 - 701
  • [7] Is prostate-specific antigen progression a surrogate for objective clinical progression in early prostate cancer?
    Newling, D
    Carroll, K
    Morris, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 419S - 419S
  • [8] Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression
    Akbay, Erdem
    Bozlu, Murat
    Cayan, Selahittin
    Kara, Pelin Ozcan
    Tek, Mesut
    Aytekin, Cuma
    AGING MALE, 2017, 20 (03): : 175 - 183
  • [9] Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression
    Perner, SR
    Hofer, MD
    Li, H
    Kuefer, R
    Gschwend, J
    Hautmann, R
    Moeller, P
    Rubin, MA
    LABORATORY INVESTIGATION, 2006, 86 : 155A - 155A
  • [10] THE CENTRAL ROLE OF PROSTATE-SPECIFIC ANTIGEN IN DIAGNOSIS AND PROGRESSION OF PROSTATE-CANCER
    STAMEY, TA
    JOURNAL OF UROLOGY, 1995, 154 (04): : 1418 - 1419
12345